Sandbox : anmol: Difference between revisions
Jump to navigation
Jump to search
Line 88: | Line 88: | ||
*Fetal alcohol syndrome | *Fetal alcohol syndrome | ||
*Retinoid embryopathy | *Retinoid embryopathy | ||
*Associational arhinencephalia | *Associational arhinencephalia | ||
(CHARGE) syndrome (coloboma, heart disease, choanal atresia, retarded growth and development, genital anomalies, ear anomalies and/or DiGeorge syndrome) | |||
DiGeorge syndrome | |||
*Cardiofacial–DiGeorge–Kenny-Caffey syndrome (ie, absent parathyroid tissue, growth retardation, medullary stenosis of tubular bones) | *Cardiofacial–DiGeorge–Kenny-Caffey syndrome (ie, absent parathyroid tissue, growth retardation, medullary stenosis of tubular bones) | ||
*Kearns-Sayre syndrome (ie, mitochondrial myopathy, ophthalmoplegia, retinal degeneration, cardiac conduction defects, primary hypoparathyroidism) | *Kearns-Sayre syndrome (ie, mitochondrial myopathy, ophthalmoplegia, retinal degeneration, cardiac conduction defects, primary hypoparathyroidism) | ||
*Barakat syndrome | *Barakat syndrome al retardation, and seizures | ||
*Familial isolated hypoparathyroidism | *Familial isolated hypoparathyroidism | ||
*Sanjad-Sakati syndrome (hypoparathyroidism – intellectual disability – dysmorphism) | *Sanjad-Sakati syndrome (hypoparathyroidism – intellectual disability – dysmorphism) | ||
*Isolated | |||
**Autosomal dominant | |||
***Autosomal dominant familial isolated hypoparathyroidism caused by PTH gene mutation<ref name="pmid2212001">{{cite journal |vauthors=Arnold A, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM |title=Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism |journal=J. Clin. Invest. |volume=86 |issue=4 |pages=1084–7 |year=1990 |pmid=2212001 |pmc=296835 |doi=10.1172/JCI114811 |url=}}</ref> | |||
***Autosomal dominant hypocalcemia<ref name="pmid27803672">{{cite journal |vauthors=Roszko KL, Bi RD, Mannstadt M |title=Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2 |journal=Front Physiol |volume=7 |issue= |pages=458 |year=2016 |pmid=27803672 |pmc=5067375 |doi=10.3389/fphys.2016.00458 |url=}}</ref> | |||
****Autosomal dominant hypocalcemia type 1 | |||
*****Calcium-sensing activating mutation | |||
*****Most common genetic form of hypoparathyroidism | |||
*****Also known as familial hypercalciuric hypocalcemia | |||
*****The activating mutation results in gain in function | |||
*****Calcium-sensing receptor gene activating mutation can also cause Bartter syndrome type 5.This mutation cause the inhibition of apical potassium channel in the thick ascending limb of the loop of Henle in the kidney.<ref name="pmid17048213">{{cite journal |vauthors=Vezzoli G, Arcidiacono T, Paloschi V, Terranegra A, Biasion R, Weber G, Mora S, Syren ML, Coviello D, Cusi D, Bianchi G, Soldati L |title=Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome |journal=J. Nephrol. |volume=19 |issue=4 |pages=525–8 |year=2006 |pmid=17048213 |doi= |url=}}</ref><ref name="pmid25932037">{{cite journal |vauthors=Choi KH, Shin CH, Yang SW, Cheong HI |title=Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C |journal=Korean J Pediatr |volume=58 |issue=4 |pages=148–53 |year=2015 |pmid=25932037 |pmc=4414630 |doi=10.3345/kjp.2015.58.4.148 |url=}}</ref> | |||
****Autosomal dominant hypocalcemia type 2 | |||
*****G protein G11 (GNA11) mutation | |||
***Autosomal dominant familial isolated hypoparathyroidism caused by caused by glial cells missing 2 (GCM2) gene mutation - Dominant negative effect<ref name="pmid18712808">{{cite journal |vauthors=Canaff L, Zhou X, Mosesova I, Cole DE, Hendy GN |title=Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism |journal=Hum. Mutat. |volume=30 |issue=1 |pages=85–92 |year=2009 |pmid=18712808 |doi=10.1002/humu.20827 |url=}}</ref> | |||
**Autosomal recessive | |||
***Autosomal recessive familial isolated hypoparathyroidism caused by PTH gene mutation<ref name="pmid10523031">{{cite journal |vauthors=Sunthornthepvarakul T, Churesigaew S, Ngowngarmratana S |title=A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism |journal=J. Clin. Endocrinol. Metab. |volume=84 |issue=10 |pages=3792–6 |year=1999 |pmid=10523031 |doi=10.1210/jcem.84.10.6070 |url=}}</ref> | |||
***Autosomal recessive familial isolated hypoparathyroidism caused by glial cells missing 2 (GCM2) gene mutation<ref name="pmid11602629">{{cite journal |vauthors=Ding C, Buckingham B, Levine MA |title=Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB |journal=J. Clin. Invest. |volume=108 |issue=8 |pages=1215–20 |year=2001 |pmid=11602629 |pmc=209530 |doi=10.1172/JCI13180 |url=}}</ref><ref name="pmid18712808">{{cite journal |vauthors=Canaff L, Zhou X, Mosesova I, Cole DE, Hendy GN |title=Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism |journal=Hum. Mutat. |volume=30 |issue=1 |pages=85–92 |year=2009 |pmid=18712808 |doi=10.1002/humu.20827 |url=}}</ref> | |||
**X-linked | |||
==References== | ==References== |
Revision as of 16:44, 20 September 2017
Hyperparathyroidism Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sandbox : anmol On the Web |
American Roentgen Ray Society Images of Sandbox : anmol |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Classification
Classification of hyperparathyridism | |||
---|---|---|---|
Features | Primary hyperparathyroidism | Secondary hyperparathyroidism | Tertiary hyperparathyroidism |
Pathology | Hyperfunction of parathyroid cells due to hyperplasia, adenoma or carcinoma. | Physiological stimulation of parathyroid in response to hypocalcaemia. | Following long term physiological stimulation leading to hyperplasia. |
Cause | |||
Associations | May be associated with multiple endocrine neoplasia. | Usually due to chronic renal failure or other causes of Vitamin D deficiency. | Seen in chronic renal failure. |
Serum calcium | High | Low/Normal | High |
Serum phosphate | Low/Normal | High | High |
Management | Usually surgery if symptomatic. Cincacalcet can be considered in those not fit for surgery. | Treatment of underlying cause. | Usually cinacalcet or surgery in those that don't respond. |
Causes
Common Causes
- Post-surgical (most common cause)[1]
- Thyroidectomy
- Parathyroidectomy
- Radical neck dissection
- Autoimmune (2nd most common cause)[2]
- Polyglandular autoimmune syndrome type 1
- Isolated autoimmune hypoparathyroidism
Less Common Causes
- Infiltration and/or destruction of parathyroid glands
- Metal overload
- Iron overload
- Hemochromatosis
- Thalassemia ( due to repeated blood transfusion)
- Copper overload
- Wilson's disease
- Aluminium deposition
- Usually seen in patients with end-stage renal disease on hemodialysis
- Hypermagnesemia
- Iron overload
- Radiation-induced destruction parathyroid glands
- Hypomagnesemia (reversible)
- Metastatic disease
- Granulomatous disease
- Amyloidosis
- Syphilis
- Metal overload
- Progressive systemic sclerosis
- Neonatal cause
- Maternal hyperparathyroidism
- Genetic causes
Genetic Causes
- Isolated primary hypoparathyroidism
- X-linked primary hypoparathyroidism (band Xq26-Xq27)
- X autosomal-recessive primary hypoparathyroidism
- Branchial dysgenesis (DiGeorge syndrome)
- Chromosomal defects dup(1q),del(5p),dup(8q),del(10q),del(22q)
- Monogenic hypoparathyroidism
- Velocardiofacial (Shprintzen) syndrome (CATCH 22 [for cardiac, abnormal facies, thymic aplasia, cleft palate, and hypocalcemia with 22q deletion] is a mnemonic for the features of this syndrome.)
- Zellweger syndrome
- Diabetic embryopathy
- Fetal alcohol syndrome
- Retinoid embryopathy
- Associational arhinencephalia
(CHARGE) syndrome (coloboma, heart disease, choanal atresia, retarded growth and development, genital anomalies, ear anomalies and/or DiGeorge syndrome) DiGeorge syndrome
- Cardiofacial–DiGeorge–Kenny-Caffey syndrome (ie, absent parathyroid tissue, growth retardation, medullary stenosis of tubular bones)
- Kearns-Sayre syndrome (ie, mitochondrial myopathy, ophthalmoplegia, retinal degeneration, cardiac conduction defects, primary hypoparathyroidism)
- Barakat syndrome al retardation, and seizures
- Familial isolated hypoparathyroidism
- Sanjad-Sakati syndrome (hypoparathyroidism – intellectual disability – dysmorphism)
- Isolated
- Autosomal dominant
- Autosomal dominant familial isolated hypoparathyroidism caused by PTH gene mutation[3]
- Autosomal dominant hypocalcemia[4]
- Autosomal dominant hypocalcemia type 1
- Calcium-sensing activating mutation
- Most common genetic form of hypoparathyroidism
- Also known as familial hypercalciuric hypocalcemia
- The activating mutation results in gain in function
- Calcium-sensing receptor gene activating mutation can also cause Bartter syndrome type 5.This mutation cause the inhibition of apical potassium channel in the thick ascending limb of the loop of Henle in the kidney.[5][6]
- Autosomal dominant hypocalcemia type 2
- G protein G11 (GNA11) mutation
- Autosomal dominant hypocalcemia type 1
- Autosomal dominant familial isolated hypoparathyroidism caused by caused by glial cells missing 2 (GCM2) gene mutation - Dominant negative effect[7]
- Autosomal recessive
- X-linked
- Autosomal dominant
References
- ↑ Marx SJ (2000). "Hyperparathyroid and hypoparathyroid disorders". N. Engl. J. Med. 343 (25): 1863–75. doi:10.1056/NEJM200012213432508. PMID 11117980.
- ↑ Eisenbarth GS, Gottlieb PA (2004). "Autoimmune polyendocrine syndromes". N. Engl. J. Med. 350 (20): 2068–79. doi:10.1056/NEJMra030158. PMID 15141045.
- ↑ Arnold A, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM (1990). "Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism". J. Clin. Invest. 86 (4): 1084–7. doi:10.1172/JCI114811. PMC 296835. PMID 2212001.
- ↑ Roszko KL, Bi RD, Mannstadt M (2016). "Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2". Front Physiol. 7: 458. doi:10.3389/fphys.2016.00458. PMC 5067375. PMID 27803672.
- ↑ Vezzoli G, Arcidiacono T, Paloschi V, Terranegra A, Biasion R, Weber G, Mora S, Syren ML, Coviello D, Cusi D, Bianchi G, Soldati L (2006). "Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome". J. Nephrol. 19 (4): 525–8. PMID 17048213.
- ↑ Choi KH, Shin CH, Yang SW, Cheong HI (2015). "Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C". Korean J Pediatr. 58 (4): 148–53. doi:10.3345/kjp.2015.58.4.148. PMC 4414630. PMID 25932037.
- ↑ 7.0 7.1 Canaff L, Zhou X, Mosesova I, Cole DE, Hendy GN (2009). "Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism". Hum. Mutat. 30 (1): 85–92. doi:10.1002/humu.20827. PMID 18712808.
- ↑ Sunthornthepvarakul T, Churesigaew S, Ngowngarmratana S (1999). "A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism". J. Clin. Endocrinol. Metab. 84 (10): 3792–6. doi:10.1210/jcem.84.10.6070. PMID 10523031.
- ↑ Ding C, Buckingham B, Levine MA (2001). "Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB". J. Clin. Invest. 108 (8): 1215–20. doi:10.1172/JCI13180. PMC 209530. PMID 11602629.